EKF Diagnostics (LON:EKF) Shares Down 7% – Should You Sell?

EKF Diagnostics Holdings plc (LON:EKF) shares were down 7% during mid-day trading on Friday . The company traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). Approximately 2,281,890 shares traded hands during mid-day trading, an increase of 404% from the average daily volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Price Performance

The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of £116.76 million, a price-to-earnings ratio of 19.26 and a beta of 0.57. The stock’s 50 day moving average price is GBX 29.18 and its two-hundred day moving average price is GBX 26.63.

EKF Diagnostics (LON:EKF) last posted its quarterly earnings results on Tuesday, September 16th. The company reported GBX 0.43 earnings per share for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. Analysts anticipate that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.